
Medsilo Pharmaceuticals Private Limited
About Medsilo Pharmaceuticals Private Limited
Data last updated:
Medsilo Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2014PTC096613. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santhanam Alexander and Ravikumar Laila Saranlal.
Its last annual general meeting (AGM) was held on 26 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Old No.39 New No.22 Ground Floor Brahmin Street Velachery, Chennai, Tamil Nadu, India – 600042.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.36 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹14.31 Lakh (net margin -10.5%) and EBITDA of -₹3.37 Lakh (EBITDA margin -2.5%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Medsilo Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOld No.39 New No.22 Ground Floor Brahmin Street Velachery, Chennai, Tamil Nadu, India – 600042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medsilo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medsilo Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Medsilo Pharmaceuticals Private Limited, buy the company report.
Financials of Medsilo Pharmaceuticals Private Limited
FY 2018 filings availableMedsilo Pharmaceuticals Private Limited reported revenue of ₹1.36 Cr (down 39% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 48%. EBITDA fell 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹1.36 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.37 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹14.31 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -2.5% | |||
| Net Profit Margin | -10.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medsilo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medsilo Pharmaceuticals Private Limited
Medsilo Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santhanam Alexander | Director | 21 Jul 2014 | 12 Years 3 Months | Current |
| Ravikumar Laila Saranlal | Director | 21 Jul 2014 | 12 Years 3 Months | Current |
Auditor
Medsilo Pharmaceuticals Private Limited is audited by GAYATHRI DHANABAL & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAYATHRI DHANABAL & CO | FY 2018 | 016649S |
Shareholding
The shareholding of Medsilo Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medsilo Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Mar 2015 | 10565375 | State Bank of Travancore | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medsilo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medsilo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medsilo Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Medsilo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medsilo Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Christeena ceased to be Director on 23 Aug 2021.
Frequently asked questions
Medsilo Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 July 2014 (12+ years old) and is registered under CIN U74900TN2014PTC096613.
Medsilo Pharmaceuticals has 2 current directors:
- Santhanam Alexander - Director
- Ravikumar Laila Saranlal - Director
The latest financial statements of Medsilo Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 26 September 2018. Year-wise statements from 2015 are in the company report.
No. Medsilo Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Medsilo Pharmaceuticals is U74900TN2014PTC096613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medsilo Pharmaceuticals was incorporated on 21 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Christeena ceased to be Director on 23 Aug 2021. Ravikumar Laila Saranlal was appointed as Director on 21 Jul 2014. Santhanam Alexander was appointed as Director on 21 Jul 2014.
The registered office of Medsilo Pharmaceuticals is at Old No.39 New No.22 Ground Floor Brahmin Street Velachery, Chennai, Tamil Nadu, India – 600042.
Medsilo Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medsilo Pharmaceuticals has open charges of ₹50 Lakh and no satisfied charges on record as per latest MCA filings.

